Medicine Description plavedamol 75 mg
plavedamol 75 mg tablets is a medication that combines aspirin and clopidogrel, two antiplatelet agents that work synergistically to prevent blood clot formation. Aspirin inhibits cyclooxygenase-1 (COX-1) enzyme, leading to decreased thromboxane A2 production, which reduces platelet aggregation. Clopidogrel, on the other hand, is a prodrug that, once activated, irreversibly inhibits the P2Y12 receptor on the platelet surface, further preventing platelet activation and aggregation. Together, these mechanisms effectively diminish the risk of thrombus formation in patients with atherosclerotic disease, thereby improving cardiovascular outcomes.
Indications and Uses of plavedamol 75 mg tablets
- Management of acute coronary syndrome
- Prevention of cardiovascular events in high-risk patients
- Support for patients with a history of myocardial infarction
- Indicated for patients with peripheral artery disease
- Risk reduction in those with a history of stroke or transient ischemic attack
Side Effects of plavedamol 75 mg tablets
- Gastrointestinal upset
- Increased risk of bleeding
- Allergic reactions
- Skin rashes
- Headache
Storage and Handling
Store plavedamol 75 mg tablets in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and ensure the medication is stored in its original packaging to protect it from environmental factors.
Patient Advice and Precautions
Patients should be advised to inform their healthcare provider of any existing medical conditions, particularly bleeding disorders or gastrointestinal issues. Regular monitoring for signs of bleeding is essential, and patients should avoid concurrent use of other medications that may increase bleeding risk without consulting a healthcare professional. It is crucial to maintain adherence to prescribed therapy and report any unusual symptoms to a healthcare provider promptly.